StockMacro
Company, fund or insider

Help

Menu

Fate Therapeutics

FATE on XNAS, Fate Therapeutics, Inc.

Measures activity, not value. Not investment advice.

Sharp changes

0

federal obligations jump, first federal award, first award from a new federal agency

Window
Record type

What usually follows Federal contracts growth was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it

What the numbers say

  • Latest record: new Department of Defense grant W81XWH1110340 ($2.1M), public on 23 May 2011.

Sharp changes

0 in all loaded history, strongest first

No sharp change of this kind in all loaded history.

The records

Newest first, by the day each became public

Showing 1 to 1 of 1.
Became publicTypeRecord
23 May 2011New federal grantnew Department of Defense grant W81XWH1110340 ($2.1M)